VTRS today
$21.07+$0.01 (+0.02%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minLeaning Bearish
5 minStrong Bullish
Daily trend turns down below $17.86
Key levels
Support$19.50
Support$18.64
Latest news & SEC filings
AnalystUBS Raises Viatris Price Target to $28, Keeps Buy Rating
All VTRS news →About Viatris
Viatris is a global pharmaceutical company that develops, makes, and sells medicines across generics, established brands, and innovative products. Its portfolio spans therapeutic areas such as cardiovascular, central nervous system, diabetes, and ophthalmology. The company serves patients, pharmacies, wholesalers, governments, and healthcare providers through operations in Developed Markets, Emerging Markets, JANZ, and Greater China. It runs production and logistics facilities in multiple regions around the world.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Viatris Inc (VTRS)
What Is the Price Target for VTRS?
SEPT Low Target
$14.00
SEPT Mid Target
$20.00
SEPT High Target
$28.00
Analyst Consensus
$20.00
Is VTRS a Buy or Sell Right Now?
Thesis
- •Revenue growing -3.0% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VTRS.
Start Free Trial →Is VTRS Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$25.88
26
Moat Score
NONE
3/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with VTRS?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Campbell Paul | officer | Sale | 50,076 | $810K | Jun 25, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →VTRS Growth Story
Revenue YoY
-3.0%
3yr Revenue CAGR
-4.2%
EPS Growth YoY
-466.04%
FCF Growth YoY
-2.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for VTRS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for VTRS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:41:18 | $21.05 | 2,400 | $$51K | BUY |
| 14:36:29 | $21.02 | 1,000 | $$21K | SELL |
| 14:35:45 | $21.07 | 4,400 | $$93K | BUY |
| 14:35:35 | $21.04 | 1,731 | $$36K | SELL |
| 14:33:13 | $21.11 | 1,000 | $$21K | BUY |
5 dark pool trades shown · $$222K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Viatris Inc (VTRS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →VTRS — frequently asked questions
What is VTRS stock price today?
Viatris Inc (VTRS) is at $21.07, up 0.02% (+$0.01) at the Nov 12, 2026 close.
Why is VTRS stock moving today?
Latest VTRS news — Nov 6, 2026: UBS Raises Viatris Price Target to $28, Keeps Buy Rating
Why did VTRS stock move on Oct 30, 2026?
Viatris shares closed at $19.03, down 1.50% on the day, even as the company advanced its proposed acquisition of Pacira BioSciences. A Viatris subsidiary, Peach Purchaser Sub, launched a tender offer to buy Pacira for $36.50 per share in cash, following Viatris's initial buyout bid at the same price.
What is the VTRS price target?
The average analyst price target for VTRS is $20.00, ranging from $14 to $28, based on 8 analysts.
What do analysts rate VTRS?
Analyst ratings for VTRS: 2 Buy, 8 Hold, 0 Sell — consensus Hold.
Did VTRS beat earnings?
VTRS last reported on Nov 5, 2026: EPS $0.71 vs $0.64 expected — a beat of 11.5%.
Does VTRS pay a dividend?
Yes. VTRS's dividend yield is 3.85%.
What are VTRS support and resistance levels?
Support: $19.50, $18.64, $17.86.
What are insiders doing with VTRS?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on VTRS?
Nov 6, 2026: UBS Raises Viatris Price Target to $28, Keeps Buy Rating